Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Growth Small Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Ivy Micro Cap Growth Fund

+ Add to Watchlist

IGWAX:US

24.86 USD 0.32 1.30%

As of 09:29:30 ET on 05/27/2015.

Snapshot for Ivy Micro Cap Growth Fund (IGWAX)

Year To Date: +1.70% 3-Month: +0.41% 3-Year: +17.13% 52-Week Range: 20.83 - 25.58
1-Month: -2.08% 1-Year: +9.09% 5-Year: +15.41% Beta vs RUO: 1.00

Mutual Fund Chart for IGWAX

No chart data available.
  • IGWAX:US 24.86
  • 1M
  • 1Y
Interactive IGWAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IGWAX

Ivy Micro Cap Growth Fund is an open-end fund incorporated in the USA. The objective is long-term capital appreciation. The Fund will invest at least 80% of its assets in the equity securities of domestic micro cap companies.

Inception Date: 02-17-2009 Telephone: 1-800-456-5111
Managers: PAUL K LECOQ / KENNETH F MCCAIN
Web Site: www.ivyfunds.com

Fundamentals for IGWAX

NAV (on 2015-05-27) 24.86
Assets (M) (on 2014-06-30) 256.50
Fund Leveraged N
Minimum Investment 750.00
Minimum Subsequent Investment 50.00

Dividends for IGWAX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-11) 0.41
Dividend Yield (ttm) 5.62

Fees & Expenses for IGWAX

Front Load 5.75
Back Load 1.00
Current Mgmt Fee 0.95
Redemption Fee 2.00
12b1 Fee 0.25
Expense Ratio 1.64

Top Fund Holdings for IGWAX

Filing Date: 03/31/2015
Name Position Value % of Total
Auspex Pharmaceuticals Inc 84,800 8,502,896 3.572%
Repligen Corp 184,200 5,592,312 2.349%
Aerie Pharmaceuticals Inc 147,500 4,622,650 1.942%
Quidel Corp 160,000 4,316,800 1.813%
2U Inc 168,700 4,315,346 1.813%
Callidus Software Inc 330,500 4,190,740 1.760%
NewLink Genetics Corp 70,700 3,867,997 1.625%
Retrophin Inc 157,300 3,768,908 1.583%
Pernix Therapeutics Holdings I 344,700 3,684,843 1.548%
Covenant Transportation Group 111,100 3,684,076 1.547%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil